However, it should be noted that coregulator expression changes with disease and that AR signalling is not confined to cancer cells, thus drugs targeting coregulators may have different effects with disease progression and may affect AR signalling in non-cancer tissue with unknown consequences. The gene discussed is AR; the disease is cancer.